By
Drug Target Review2025-06-04T12:31:13
Scientists have used AI to design a molecule that disrupts a key protein interaction driving up to 70 percent of cancers - once thought impossible to drug.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-12T09:31:00Z
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2023-07-03T10:28:23
Sponsored by Merck
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2026-06-24T13:00:00 2026-06-24T14:00:00
Sponsored by HUB Organoids
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-09-27T10:36:50
Sponsored by NanoTemper Technologies
2023-11-24T12:06:45
Sponsored by Quantum-Si
Site powered by Webvision Cloud